Skip to main content

Advertisement

SpringerLink
Log in

Ductal carcinoma in situ of the breast

  • Review
  • Published:
Oncology Reviews

Abstract

Ductal carcinoma in situ (DCIS) of the breast is a noninvasive form of breast cancer that has increased in incidence over the past several decades secondary to screening mammography. DCIS now represents 20–30% of all newly diagnosed cases of breast cancer. Patients with DCIS typically present with an abnormal mammogram, and diagnosis is most commonly obtained with an image-guided biopsy. Historically, mastectomy was considered the primary curative option for patients with DCIS. However, treatment of DCIS continues to evolve, and now treatment strategies also include breast-conserving therapy, which consists of local excision followed by radiation therapy or local excision alone. Multiple randomized trials have confirmed a decrease in ipsilateral breast tumor recurrence in patients treated with local excision followed by radiation therapy compared with local excision alone. Ongoing clinical trials attempt to identify a subgroup of DCIS patients at low risk for recurrence who may not benefit from radiation therapy. In addition, because the majority of ipsilateral breast tumor recurrences occur near the original primary tumor site, partial breast irradiation is currently under investigation as a treatment option for DCIS patients. Randomized trials have shown tamoxifen can reduce the risk of ipsilateral and contralateral breast tumor recurrences while the role of aromatase inhibitors is the subject of current clinical trials. DCIS represents a complex pathologic entity, and treatment optimization requires a multidisciplinary approach.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8
Fig. 9
Fig. 10
Fig. 11
Fig. 12
Fig. 13
Fig. 14
Fig. 15

Similar content being viewed by others

Abbreviations

CT:

Computed tomographic, computed tomography

DCIS:

Ductal carcinoma in situ

MRI:

Magnetic resonance imaging

NSABP:

National Surgical Adjuvant Breast and Bowel Project

References

  1. Simon MS, Lemanne D, Schwartz AG, Martino S, Swanson GM (1993) Recent trends in the incidence of in situ and invasive breast cancer in the Detroit metropolitan area (1975–1988). Cancer 71(3):769–774

    Article  CAS  PubMed  Google Scholar 

  2. Lagios MD (1993) Heterogeneity of ductal carcinoma in situ of the breast. J Cell Biochem Suppl 17G:49–52

    Article  CAS  PubMed  Google Scholar 

  3. Ernster VL, Barclay J, Kerlikowske K, Grady D, Henderson C (1996) Incidence of and treatment for ductal carcinoma in situ of the breast. JAMA 275(12):913–918

    Article  CAS  PubMed  Google Scholar 

  4. Harras A (ed) (1996) Cancer rates and risks, 4th edn. Cancer Statistics Branch, Division of Cancer Prevention and Control, US Department of Health and Human Services, Public Health Service, National Institutes of Health, NIH Publication 96-69, Bethesda

  5. Ernster VL, Barclay J, Kerlikowske K, Wilkie H, Ballard-Barbash R (2000) Mortality among women with ductal carcinoma in situ of the breast in the population-based surveillance, epidemiology and end results program. Arch Intern Med 160(7):953–958

    Article  CAS  PubMed  Google Scholar 

  6. Holland R, Hendriks JH, Vebeek AL, Mravunac M, Schuurmans Stekhoven JH (1990) Extent, distribution, and mammographic/histological correlations of breast ductal carcinoma in situ. Lancet 335(8688):519–522

    Article  CAS  PubMed  Google Scholar 

  7. Evans A, Pinder S, Wilson R, Sibbering M, Poller D, Elston C, Ellis I (1994) Ductal carcinoma in situ of the breast: correlation between mammographic and pathologic findings. AJR Am J Roentgenol 162(6):1307–1311

    CAS  PubMed  Google Scholar 

  8. Stomper PC, Connolly JL, Meyer JE, Harris JR (1989) Clinically occult ductal carcinoma in situ detected with mammography: analysis of 100 cases with radiologic-pathologic correlation. Radiology 172(1):235–241

    CAS  PubMed  Google Scholar 

  9. Knutzen AM, Gisvold JJ (1993) Likelihood of malignant disease for various categories of mammographically detected, nonpalpable breast lesions. Mayo Clin Proc 68(5):454–460

    CAS  PubMed  Google Scholar 

  10. Liberman L, Morris EA, Dershaw DD, Abramson AF, Tan LK (2003) Ductal enhancement on MR imaging of the breast. AJR Am J Roentgenol 181(2):519–525

    PubMed  Google Scholar 

  11. Tillman GF, Orel SG, Schnall MD, Schultz DJ, Tan JE, Solin LJ (2002) Effect of breast magnetic resonance imaging on the clinical management of women with early-stage breast carcinoma. J Clin Oncol 20(16):3413–3423

    Article  PubMed  Google Scholar 

  12. Liberman L, Morris EA, Dershaw DD, Abramson AF, Tan LK (2003) MR imaging of the ipsilateral breast in women with percutaneously proven breast cancer. AJR Am J Roentgenol 180(4):901–910

    PubMed  Google Scholar 

  13. Silverstein MJ, Gierson ED, Waisman JR, Senofsky GM, Colburn WJ, Gamagami P (1994) Axillary lymph node dissection for T1a breast carcinoma: is it indicated? Cancer 73(3):664–667

    Article  CAS  PubMed  Google Scholar 

  14. Sunshine JA, Moseley HS, Fletcher WS, Krippaehne WW (1985) Breast carcinoma in situ: a retrospective review of 112 cases with a minimum 10 year follow-up. Am J Surg 150(1):44–51

    Article  CAS  PubMed  Google Scholar 

  15. Farrow JH (1970) Current concepts in the detection and treatment of the earliest of the early breast cancers. Cancer 25(2):468–477

    Article  CAS  PubMed  Google Scholar 

  16. Silverstein MJ, Barth A, Poller DN, Gierson ED, Colburn WJ, Waisman JR, Gamagami P (1995) Ten-year results comparing mastectomy to excision and radiation therapy for ductal carcinoma in situ of the breast. Eur J Cancer 31A(9):1425–1427

    Article  CAS  PubMed  Google Scholar 

  17. Kinne DW, Petrek JA, Osborne MP, Fracchia AA, DePalo AA, Rosen PP (1989) Breast carcinoma in situ. Arch Surg 124(1):33–36

    CAS  PubMed  Google Scholar 

  18. Schuh ME, Nemoto T, Penetrante RB, Rosner D, Dao TL (1986) Intraductal carcinoma: analysis of presentation, pathologic findings, and outcome of disease. Arch Surg 121(11):1303–1307

    Article  CAS  PubMed  Google Scholar 

  19. Fisher B, Costantino J, Redmond C, Fisher E, Margolese R, Dimitrov N, Wolmark N, Wickerham DL, Deutsch M, Ore L, Mamounas E, Poller W, Kavanah M, 1581 (1993) Lumpectomy compared with lumpectomy and radiation therapy for the treatment of intraductal breast cancer. N Engl J Med 328(22):1581–1586

    Article  CAS  PubMed  Google Scholar 

  20. Fisher B, Land S, Mamounas E, Dignam J, Fisher ER, Wolmark N (2001) Prevention of invasive breast cancer in women with ductal carcinoma in situ: an update of the National Surgical Adjuvant Breast and Bowel Project experience. Semin Oncol 28(4):400–418

    Article  CAS  PubMed  Google Scholar 

  21. Kurtz JM, Jacquemier J, Torhorst J, Spitalier JM, Amalric R, Hunig R, Walther E, Harder F, Almendral A, Brandone H, Ayme Y, Roth J (1989) Conservation therapy for breast cancers other than infiltrating ductal carcinoma. Cancer 63(8):1630–1635

    Article  CAS  PubMed  Google Scholar 

  22. Kuske RR, Bean JM, Garcia DM, Perez CA, Andriole D, Philpott G, Fineberg B (1993) Breast conservation therapy for intraductal carcinoma of the breast. Int J Radiat Oncol Biol Phys 26(3):391–396

    CAS  PubMed  Google Scholar 

  23. Silverstein MJ, Cohlan BF, Gierson ED, Furmanski M, Gamagami P, Colburn WJ, Lewinsky BS, Waisman JR (1992) Duct carcinoma in situ: 227 cases without microinvasion. Eur J Cancer 28(2–3):630–634

    Article  CAS  PubMed  Google Scholar 

  24. Solin LJ, Kurtz J, Fourquet A, Amalric R, Recht A, Bornstein BA, Kuske R, Taylor M, Barrett W, Fowble B, Haffty B, Schultz DJ, Yeh IT, McCormick B, McNeese M (1996) Fifteen-year results of breast-conserving surgery and definitive breast irradiation for the treatment of ductal carcinoma in situ of the breast. J Clin Oncol 14(3):754–763

    CAS  PubMed  Google Scholar 

  25. Bijker N, Meijnen P, Peterse JL, Bogaerts J, Van Hoorebeeck I, Julien JP, Gennaro M, Rouanet P, Avril A, Fentiman IS, Bartelink H, Rutgers EJ (2006) EORTC Breast Cancer Cooperative Group; EORTC Radiotherapy Group. Breast-conserving treatment with or without radiotherapy in ductal carcinoma-in situ: ten-year results of European Organisation for Research and Treatment of Cancer Randomized Phase III Trial 10853: a study by the EORTC Breast Cancer Cooperative Group and EORTC Radiotherapy Group. J Clin Oncol 24(21):3381–3387

    Article  PubMed  Google Scholar 

  26. Houghton J, George WD, Cuzick J, Duggan C, Fentiman IS, Spittle M, UK Coordinating Committee on Cancer Research, Ductal Carcinoma in situ Working Party, DCIS trialists in the UK, Australia, and New Zealand (2003) Radiotherapy and tamoxifen in women with completely excised ductal carcinoma in situ of the breast in the UK, Australia, and New Zealand: randomised controlled trial. Lancet 362(9378):95–102

    Google Scholar 

  27. Lagios MD, Margolin FR, Westdahl PR, Rose (1989) Mammographically detected duct carcinoma in situ: frequency of local recurrence following tylectomy and prognostic effect of nuclear grade on local recurrence. Cancer 63(4):618–624

    Article  CAS  PubMed  Google Scholar 

  28. Schwartz GF, Finkel GC, Garcia JC, Patchefsky AS (1992) Subclinical ductal carcinoma in situ of the breast: treatment by local excision and surveillance alone. Cancer 70(10):2468–2474

    Article  CAS  PubMed  Google Scholar 

  29. Wong JS, Kaelin CM, Troyan SL, Gadd MA, Gelman R, Lester SC, Schnitt SJ, Sgroi DC, Silver BJ, Harris JR, Smith BL (2006) Prospective study of wide excision alone for ductal carcinoma in situ of the breast. J Clin Oncol 24(7):1031–1036

    Article  PubMed  Google Scholar 

  30. Hughes L, Wang M, Page D, Gray R, Solin L, Davidson N, Ingle J, Wood W, Eastern Cooperative Oncology Group (ECOG), North Central Cancer Treatment Group (NCCTG) (2006) Five year results of intergroup study E5194: local excision alone (without radiation treatment) for selected patients with ductal carcinoma in situ (DCIS) (abstract). In: Presented at the 29th annual San Antonio breast symposium, Dec 14–17 2006, San Antonio, Texas

  31. Radiation Therapy Oncology Group (2009) RTOG 98-04: phase III trial of observation ± tamoxifen vs RT ± tamoxifen for good risk duct carcinoma in situ (DCIS) of the female breast (Internet). http://www.rtog.org/qa/98-04/9804.pdf. Cited 10 Aug 2009

  32. Benitez PR, Streeter O, Vicini F, Mehta V, Quiet C, Kuske R, Hayes MK, Arthur D, Kuerer H, Freedman G, Keisch M, Dipetrillo T, Khan D, Hudes R (2006) Preliminary results and evaluation of MammoSite balloon brachytherapy for partial breast irradiation for pure ductal carcinoma in situ: a phase II clinical study. Am J Surg 192(4):427–433

    Article  PubMed  Google Scholar 

  33. Chao KK, Vicini FA, Wallace M, Mitchell C, Chen P, Ghilezan M, Gilbert S, Kunzman J, Benitez P, Martinez A (2007) Analysis of treatment efficacy, cosmesis, and toxicity using the MammoSite breast brachytherapy catheter to deliver accelerated partial-breast irradiation: the William Beaumont hospital experience. Int J Radiat Oncol Biol Phys 69(1):32–40

    PubMed  Google Scholar 

  34. Vicini F, Beitsch PD, Quiet CA, Keleher AJ, Garcia D, Snider HC Jr, Gittleman MA, Zannis VJ, Kuerer HM, Lyden M (2008) Three-year analysis of treatment efficacy, cosmesis, and toxicity by the American Society of Breast Surgeons MammoSite Breast Brachytherapy Registry Trial in patients treated with accelerated partial breast irradiation (APBI). Cancer 112(4):758–766

    Article  PubMed  Google Scholar 

  35. National Surgical Adjuvant Breast and Bowel Project (2009) NSABP clinical trials overview: protocol B-39/RTOG 0413 (Internet). http://www.nsabp.pitt.edu/B-39.asp. Cited 10 Aug 2009

  36. Fisher B, Dignam J, Wolmark N, Wickerham DL, Fisher ER, Mamounas E, Smith R, Begovic M, Dimitrov NV, Margolese RG, Kardinal CG, Kavanah MT, Fehrenbacher L, Oishi RH (1999) Tamoxifen in treatment of intraductal breast cancer: National Surgical Adjuvant Breast and Bowel Project B-24 randomised controlled trial. Lancet 353(9169):1993–2000

    Article  CAS  PubMed  Google Scholar 

  37. National Surgical Adjuvant Breast and Bowel Project (2009) NSABP clinical trials overview: protocol B-35 (Internet). http://wwwnasbp.pitt.edu/B-35.asp. Cited 10 Aug 2009

  38. American College of Radiology (2009) ACR practice guidelines for the performance of screening and diagnostic mammography (Internet). http://www.acr.org/SecondaryMainMenuCategories/quality_safety/guidelines/breast/Screening_Diagnostic.aspx. Cited 10 Aug 2009

  39. Smith RA, Saslow D, Sawyer KA, Burke W, Costanza ME, Evans WP III, Foster RS Jr, Hendrick E, Eyre HJ, Sener S, American Cancer Society High-Risk Work Group, American Cancer Society Screening Older Women Work Group, American Cancer Society Mammography Work Group, American Cancer Society Physical Examination Work Group, American Cancer Society New Technologies Work Group, American Cancer Society Breast Cancer Advisory Group, American Cancer Society (2003) Guidelines for breast cancer screening: update. CA Cancer J Clin 53(3):141–169

    Google Scholar 

  40. Wazer DE, Arthur DW (2008) Breast: stage Tis. In: Halperin EC, Perez CA, Brady LW (eds) Perez and Brady’s principles and practice of radiation oncology, 5th edn. Wolters Kluwer Health, Philadelphia, pp 1162–1174

Download references

Conflict of interest statement

The authors declare that they have no conflict of interest to the publication of this article.

Author information

Authors and Affiliations

  1. Department of Radiation Oncology, Mayo Clinic, 4500 San Pablo Road, Jacksonville, FL, 32224, USA

    Jennifer L. Peterson, Laura A. Vallow & Steven J. Buskirk

  2. Department of Internal Medicine, Mayo Clinic, 4500 San Pablo Road, Jacksonville, FL, 32224, USA

    Stephanie L. Hines

Authors
  1. Jennifer L. Peterson
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Laura A. Vallow
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Stephanie L. Hines
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Steven J. Buskirk
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Laura A. Vallow.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Peterson, J.L., Vallow, L.A., Hines, S.L. et al. Ductal carcinoma in situ of the breast. Oncol Rev 3, 237–246 (2009). https://doi.org/10.1007/s12156-009-0027-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12156-009-0027-2

Keywords

Search

Navigation